GO
Loading...

Sanofi says Lyxumia diabetes drug studies positive

Tuesday, 2 Oct 2012 | 6:21 AM ET

PARIS, Oct 2 (Reuters) - Sanofi's experimental diabetes treatment Lyxumia can slow down the rate at which food passes and can reduce blood sugar levels after a meal when given in combination with other diabetes drugs, the drugmaker said in a statement on Tuesday.

The data from late-stage studies was presented at the European Association for the Study of Diabetes (EASD) congress in Berlin.

(Reporting by Elena Berton; Editing by James Regan)

((elena.berton@thomsonreuters.com)(+33149495226)(Reuters

Messaging: elena.berton.thomsonreuters.com@reuters.net))

Keywords: SANOFI LYXUMIA/

  Price   Change %Change
SAN
---